KIT and mesenchymal cell neoplasm: According to the 2019 and 2022 World Health Organization (WHO) classifications, CD117 and DOG1 are mandatory diagnostic criteria for GISTs and should be included in all immunohistochemical panels for gastrointestinal mesenchymal tumors [3].